Gyermekkori daganatok: vizsgálatok itt: Japán
48 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan
- Where
- Chuo-Ku, Fukuoka, Kashiwa-shi, Kyoto, Nagoya, Okayama, Sapporo, Sendai
- Életkor
- 12 év and over
- People
- 100 worldwide
- Run by
- AbbVie
See details and how to joinNCT07196644 · EU 2024-518871-74-00 - No phaseTaking peopleRepotrectinib Post-Marketing Surveillance in Pediatric Patients With NTRK Fusion-Positive Tumors in Japan
- Where
- Minato-ku, Tokyo
- Életkor
- 4 év to 17 év
- People
- 20
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07755826 - 1. fázisTaking peopleClinical Trial of GAIA-102 for Refractory/Relapse Neuroblastomas and Other Malignant Pediatric Solid Tumors
- Where
- Fukuoka
- Életkor
- 1 év to 24 év
- People
- 61
- Run by
- Kyushu University
See details and how to joinNCT05608148 - 2. fázisTaking peopleA Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
- Where
- Chūōku, Fukuoka, Kobe
- Életkor
- 1 év to 39 év
- People
- 105 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05999994 - 2. fázisTaking peopleStudy to ONO-4538 in Patients With Rhabdoid Tumor
- Where
- Chiba, Chuo Ku, Fukuoka, Fukushima, Hiroshima, Kanazawa, Kobe, Kyoto, Miyagi, Nagoya, Niigata, Osaka, Sapporo, Tokyo
- Életkor
- 1 év and over
- People
- 23
- Run by
- Ono Pharmaceutical Co., Ltd.
See details and how to joinNCT06622941 - 1/2. fázisTaking peopleA Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participants With Merkel Cell Carcinoma (MK-3475-G21/KEYNOTE-G21)
- Where
- Chūō, Fukuoka, Kobe, Kyoto, Nagoya, Sapporo
- Életkor
- 6 hónap and over
- People
- 20
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07302347 - No phaseTaking peopleNTRK Gene Fusion - Positive Advanced or Recurrent Solid Tumors, a Rare Cancer Caused by Specific Changes in the Genes
- Where
- Multiple Locations
- People
- 100
- Run by
- Bayer
See details and how to joinNCT04945330 - No phaseTaking peopleSpecial Drug Use-results Surveillance of Tafinlar/Mekinist
- Where
- Akita, Amagasaki, Bunkyo Ku, Chiba, Chuo Ku, Daisen, Fukuoka, Fukuyama, Funabashi, Habikino, Hiroshima, Iida, Izumisano, Kagoshima, Kashiwa, Kawagoe, Kobe, Kochi, Kurume, Kyoto, Matsumoto, Minato Ku, Mito, Morioka, Nagakute, Nagoya, Natori-shi, Ohtsu, Okayama, Osaka, Sagamihara, Saitama, Sapporo, Sendai, Setagaya-ku, Shibuya City, Shimotsuke, Shinjuku Ku, Shizuoka, Sunto Gun, Takatsuki, Toyohashi, Toyota, Wakayama, Yamagata, Yokohama, Yoshida-gun, Yufu
- Életkor
- 6 év to 99 év
- People
- 110
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06262919 - 1. fázisTaking peopleA Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors, Hepatocellular Carcinoma (HCC), Melanoma, and Pediatric Cancer
- Where
- Chūō, Kashiwa, Niigata, Yokohama
- Életkor
- 2 év and over
- People
- 66
- Run by
- Chiome Bioscience Inc.
See details and how to joinNCT06636435 - 1/2. fázisTaking peopleA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Where
- Chuo Ku, Kashiwa, Nagoya, Osaka, Sapporo, Tōon, Yokohama, Yonago
- Életkor
- 12 év and over
- People
- 500 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00 - 3. fázisTaking peopleONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
- Where
- Chūō, Fukuoka, Kyoto, Osaka, Sapporo, Tokyo
- People
- 510 worldwide
- Run by
- Jazz Pharmaceuticals
See details and how to joinNCT05580562 · EU 2022-502051-56-00 - No phaseTaking peopleA Survey of Brentuximab Vedotin in Pediatric Participants With Hodgkin Lymphoma
- Where
- Tokyo
- Életkor
- Up to 18 év
- People
- 8
- Run by
- Takeda
See details and how to joinNCT05481437 - 1/2. fázisTaking peopleA Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Where
- Bunkyō City, Bunkyo-ku, Fukuoka, Fukushima, Hokkaido, Isehara-Shi, Kashiwa-shi, Miyagi, Nagasaki, Okayama, Osaka, Yoshida-gun
- Életkor
- 12 év and over
- People
- 606 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555 - No phaseTaking peopleSurvey of Brigatinib Used To Treat People With Non-Small Cell Lung Cancer
- Where
- Tokyo
- People
- 500
- Run by
- Takeda
See details and how to joinNCT05100069 - No phaseTaking peopleMulti-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors
- Where
- Nagoya
- People
- 1050 worldwide
- Run by
- Washington University School of Medicine
See details and how to joinNCT03141021 - No phaseTaking peopleA Post-marketing Observational Study of Tasfygo in Participants With Unresectable Biliary Tract Cancer With Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion Gene Positivity Who Progressed After Chemotherapy
- Where
- Tokyo
- People
- 60
- Run by
- Eisai Co., Ltd.
See details and how to joinNCT06793709 - No phaseLeállítvaPrimary Tumor Research and Outcomes Network
- Where
- Kanazawa
- People
- 1350 worldwide
- Run by
- AO Innovation Translation Center
See details and how to joinNCT02790983 - No phaseNot yet taking people in JapánAsian Gynecological Brachytherapy Registry in Cervical Cancer
- Where
- Maebashi, Tokyo
- People
- 1000 worldwide
- Run by
- Tata Memorial Hospital
See details and how to joinNCT07196033 - No phaseTaking peopleTransgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
- Where
- Kumamoto, Toyokawa
- People
- 50 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06357754 - No phaseTaking peopleID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
- Where
- Tokyo
- People
- 2000 worldwide
- Run by
- Stanford University
See details and how to joinNCT02848274 - No phaseTaking peopleEvaluation Using FAPI-PET Targeting Cancer-associated Fibroblasts
- Where
- Suita
- People
- 200
- Run by
- Tadashi Watabe
See details and how to joinNCT05442151 - No phaseCsak meghívásosInternational Registry of Congenital Portosystemic Shunt (IRCPSS)
- Where
- Tokyo
- Életkor
- 1 nap and over
- People
- 500 worldwide
- Run by
- Prof. Valérie Mc Lin
See details and how to joinNCT06041906 - No phaseNot yet taking people in JapánInternational Chronic Myeloid Leukemia Pediatric Study
- Where
- Tokyo
- Életkor
- Up to 18 év
- People
- 750 worldwide
- Run by
- Poitiers University Hospital
See details and how to joinNCT01281735